Kootenai Cancer — Sandpoint, Idaho

Kootenai Cancer is a clinical research site located in Sandpoint, Idaho, United States 83864.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Kootenai Cancer has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer.

Sponsors: SWOG Cancer Research Network, Eastern Cooperative Oncology Group, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kootenai Cancer?

Kootenai Cancer has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kootenai Cancer conducted?

Kootenai Cancer has 4 clinical trials on record, with 1 currently active. Their work covers Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer.

Is Kootenai Cancer accredited by Crixeo Health?

Kootenai Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kootenai Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.